The effect of intrauterine administration of human gonadotropin (HCG) on implantation and pregnancy rates in IUI (intrauterine insemination cycles) cycles: a randomized prospective study

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

LBCTR

Registry ID

LBCTR2021034751

Enrollment

200

Registered

2021-04-03

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The study involves patients suffering from infertility and willing to start an IUI procedure. IVF

Interventions

The project will involve whether administrating different doses of HCG (known as Choriomon HCG 5000 - IBSA ) along with the semen sample in the uterus or not during intrauterine insemination.

Dose

Eligibility

Sex/Gender

All

Age

18 Years to 38 Years

Inclusion criteria

Inclusion criteria: We are inviting 210 patients attending the Al Hadi IVF Center to start the infertility treatment for IUI, in which the age of the female partner is less than 38 years old.

Exclusion criteria

Exclusion criteria: sperm count less than 1 million and progressive motility less than 30% Advanced maternal age bilateral tubal stenosis

Design outcomes

Primary

Measure	Time frame
Name: Live Birth Rate;Timepoints: after 9 months of last recruitment;Measure: Alive or not	—

Secondary

Measure	Time frame
Name: Pregnancy Rate;Timepoints: after 3 months of last recruitment ;Measure: gestational sac	—

Countries

Lebanon

Contacts

Public ContactChadi Fakih

Al Hadi Laboratory and Medical Center

drchadifakih@yahoo.fr03755442

Outcome results

None listed

Source: LBCTR (via WHO ICTRP) · Data processed: Feb 7, 2026